SCHEMBL28826754

SCHEMBL28826754

OCCNCc1cccc2cc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.46
MC5R P33032 1/20 0.46
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
TERT O14746 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA1 P00915 1/20 0.42
CA4 P22748 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
SMPD1 P17405 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23877653 0.95 LMNA (0.48) MAPK1MC5RALDH1A1HPGDTERT
SCHEMBL28464377 0.83 MC5R (0.46) MAPK1MC5RHPGDTERTMEN1
SCHEMBL25195712 0.83 ATM (0.46) MAPK1MC5RALDH1A1MEN1KMT2A
SCHEMBL5870343 0.81 TERT (0.47) MAPK1MC5RHPGDTERTMEN1
Hydrochloric Acid SCHEMBL25193498 0.79 ATM (0.44) ALDH1A1MEN1KMT2AHTR1DHTR1B
SCHEMBL20962611 0.78 ALDH1A1 (0.59) ALDH1A1CA12CA2CA9LMNA
SCHEMBL3297203 0.77 PRMT5 (0.50) ALDH1A1MEN1KMT2AHTR1DHTR1B
SCHEMBL1456304 0.77 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL1506818 0.76 MC5R (0.47) MAPK1MC5RALDH1A1HPGDTERT
SCHEMBL136100 0.76 ALDH1A1 (0.46) MAPK1MC5RALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105764501-A Compositions for improving the therapeutic benefit of bisantrene 现代化制药公司 2016-07-13 CN claimed
CN-105764501-A Compositions for improving the therapeutic benefit of bisantrene 现代化制药公司 2016-07-13 CN disclosed
CN-105764502-A Combination methods for improving the therapeutic benefit of bisantrene and analogs and derivatives thereof 现代化制药公司 2016-07-13 CN disclosed